RHUMBLINE ADVISERS

Position in LEGN — Legend Biotech Corp

CIK 1115418 BOSTON, MA

Position in LEGN

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$435,134

+$77,767 QoQ

Shares Held

15,067

-23.7% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#127

of 217 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 41% Shared 0% None 59%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. LEGN ranks #196 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	396,380	$196,893,837
2	REGN	Regeneron Pharmaceuticals, Inc.	157,794	$98,390,870
3	MRNA	Moderna, Inc.	809,853	$56,714,005
4	ALNY	Alnylam Pharmaceuticals, Inc.	165,579	$49,844,246
5	INCY	Incyte Corp	428,533	$48,578,500
6	RVMD	Revolution Medicines, Inc.	226,008	$42,326,778
7	ROIV	Roivant Sciences Ltd.	1,178,789	$41,717,342
8	JAZZ	Jazz Pharmaceuticals plc	163,018	$39,282,447

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$435,134	15,067	-23.7%	Shares	Sole	2026-08-12
2026-03-31	$357,367	19,755	-2.3%	Shares	Sole	2026-05-12
2025-12-31	$439,626	20,222	0.0%	Shares	Sole	2026-02-13
2025-09-30	$659,439	20,222	-26.1%	Shares	Sole	2025-11-06
2025-06-30	$970,616	27,349	-2.4%	Shares	Sole	2025-08-12
2025-03-31	$951,023	28,029	+1.4%	Shares	Sole	2025-05-29
2024-12-31	$899,340	27,638	+5.9%	Shares	Sole	2025-05-29
2024-09-30	$1,271,560	26,094	-0.9%	Shares	Sole	2024-11-12
2024-06-30	$1,166,332	26,334	+11.4%	Shares	Sole	2024-08-01
2024-03-31	$1,325,406	23,630	+3.1%	Shares	Sole	2024-05-09
2023-12-31	$1,378,795	22,915	+4.2%	Shares	Sole	2024-02-08
2023-09-30	$1,477,404	21,995	+52.1%	Shares	Sole	2023-11-09
2023-06-30	$998,518	14,465	—	Shares	Sole	2023-08-08
No filing history on record for this holder in this stock.